Researchers have developed a new tool and technique that uses "vortex ultrasound"—a sort of ultrasonic tornado—to break down blood clots in the brain. The new approach worked more quickly than existing techniques to eliminate ...
Jan 23, 2023
0
89
Major emergencies such as terrorist attacks and natural disasters have become more complex and larger in scale, challenging the ability of first responders to deal with the overwhelming numbers of casualties. As they battle ...
Nov 18, 2022
0
2
The immune system is equipped to respond not just to external invaders—think viruses, bacteria, and parasites—but also to internal threats, namely, cancer. Yet, frequently, malignancies overcome the immune system's defenses ...
Sep 10, 2022
0
135
An international study 13 years in the making demonstrates for the first time that degradation in the way DNA is organized and regulated—known as epigenetics—can drive aging in an organism, independently of changes to ...
Jan 12, 2023
0
115
A common and widely used chemical may be fueling the rise of the world's fastest growing brain condition—Parkinson's disease. For the past 100 years, trichloroethylene (TCE) has been used to decaffeinate coffee, degrease ...
Mar 14, 2023
0
159
For those diagnosed with colorectal cancer, surgery has been the only option that offers a solution. Unfortunately, surgery is frequently complicated by disease recurrence at the site of the original cancer when microscopic ...
Apr 25, 2022
0
71
The slightest variation in a sequence of DNA can have profound effects. Modern genomics has shown that just one mutation can be the difference between successfully treating a disease and having it spread rampantly throughout ...
Jul 28, 2013
0
0
Effective hearing loss treatments have eluded medicine because once sensory cells in the inner ear called hair cells are damaged or destroyed, they cannot be regenerated. This loss of hair cells, which can be caused by aging, ...
Apr 18, 2023
2
71
Despite decades of research and tens of billions of dollars for research and treatments worldwide, the battle against cancer continues.
Several NGOs protested Thursday at the annual meeting of Novartis against the attempt by the Swiss pharmaceutical group's India company to obtain a patent for its anti-cancer drug Glivec.
Feb 23, 2012
0
0
